Recent articles, interviews or news items involving the firm or its attorneys include:


Nevrivy Patent Law Group will be attending the World Stem Cell Summit (Miami, January 2019) 


Nevrivy Patent Law Group will be exhibiting at the AIPPI World Congress (Cancun, September 2018) 


Nevrivy Patent Law Group will be exhibiting at the Biotechnology Innovation Organization International Convention (Boston, June 2018)


Nevrivy Patent Law Group will be exhibiting at the AUTM annual meeting in Phoenix, Arizona (February 2018) 


Best Pharmaceuticals IP Law Firm – Mid-Atlantic USA (Acquisition International 2017 Legal Awards) 


Daniel J. Nevrivy named Life Sciences Patent Attorney of the Year – Mid-Atlantic USA (Acquisition International 2017 Legal Awards)  


Nevrivy Patent Law Group named as one of 2016′s Most Innovative Law Firms (Acquisition International 2016 Legal Awards) 


Best Life Science Patent Law Firm – USA (Acquisition International 2016 Legal Awards)


Nevrivy Patent Law Group Named US Biotech and Pharmaceutical Patents Law Firm of the Year and US Leading Customer Service Law Firm of the Year by ACQ5 (May 2016)


Nevrivy Patent Law Group Receives Legal Award for Sustained Excellence in Biotech and Pharmaceutical Patent Law by Acquisition International (December, 2015)


Our firm will be attending the Biotechnology Industry Organization (BIO) conference in San Diego, June, 2014.


Keisha Hylton-Rodic, Ph.D. will be moderating an American Bar Association webinar entitled “The Nuts and Bolts of Patents and the Drug Approval Process,” November, 2013.


Our firm is pleased to exhibit at the American Chemical Society national meeting in Indianapolis, September, 2013.


Our firm hosts a delegation of Senior Examiners from the European Patent Office for an educational event entitled “A Conversation with EPO Examiners,” May, 2013.


“Lawyers Offer Predictions for Myriad, Diagnostic Field Based on Supreme Court’s Decision Against Prometheus ”
Genetic Engineering & Biotechnology News


Academic & Pharma Partnerships: Tapping the Ivory Tower for the Next Blockbuster, FiercePharma


“Caveats in Patent Overhaul Could Pose New Challenges for Smaller Biopharmas”
Genetic Engineering & Biotechnology News


“Implementation of European Court Decision to Ban hESC Patents Depends on National Patent Offices”
Genetic Engineering & Biotechnology News


Nevrivy Patent Law Group is exhibiting at the 2011 Entrepreneur Expo, November 14, 2011.


“Asia’s Emerging Markets Catching Up to the U.S. and Europe in Terms of Innovation”Genetic Engineering & Biotechnology News, June 2011


IP Man III, Legal Bisnow (New York) (profiling Sullivan’s IP Law Outline)


IP Lawyers Don’t Need Desks, Legal Bisnow (Washington, D.C.) (profiling Sullivan’s IP Law Outline)


“Kelli Watson Francuzenko, Life Science IP Transactional Attorney, Joins Nevrivy Patent Law Group,” Intellectual Property Today


“China gets serious about biotech,” FierceBiotech

Nevrivy Patent Law Group is sponsoring the World Stem Cell Summit, held September 21-23 in Baltimore, Maryland.


“Restoring Science to its Rightful Place in America,” Law360


“Does the U.S. biotech industry deserve a bailout?” FiercePharma and FierceBiotech